Regeneron To Buy 23andMe For $256M After Bankruptcy: Here’s What To Know
23andMe, known for its at-home DNA testing kits, is expected to be obtained by its highest bidder following a bankruptcy auction after reaching a peak valuation of $6 billion. On Monday, 23andMe announced in a press release that it’s being sold to Regeneron Pharmaceuticals, which is “a leading U.S.-based, NASDAQ-listed biotechnology company that invents, develops […]
Regeneron To Buy 23andMe For $256M After Bankruptcy: Here’s What To Know Read More »





